NYSE:MTD - Mettler-Toledo International Stock Price, Forecast & News

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International Inc. (NYSE:MTD) announced its earnings results on Thursday, February, 6th. The medical instruments supplier reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.68 by $0.10. The medical instruments supplier earned $843.97 million during the quarter, compared to the consensus estimate of $835.43 million. Mettler-Toledo International had a net margin of 18.65% and a return on equity of 118.08%. The firm's revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.85 EPS. View Mettler-Toledo International's Earnings History.

Mettler-Toledo International is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for Mettler-Toledo International.

Mettler-Toledo International issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of $24.85-25.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $25.06. The company issued revenue guidance of +~4% (implying $3.13 billion), compared to the consensus revenue estimate of $3.11 billion.

6 brokerages have issued 12 month target prices for Mettler-Toledo International's shares. Their forecasts range from $640.00 to $815.00. On average, they anticipate Mettler-Toledo International's share price to reach $758.50 in the next twelve months. This suggests that the stock has a possible downside of 0.2%. View Analyst Price Targets for Mettler-Toledo International.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There are currently 1 sell rating and 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Mettler-Toledo International.

Press coverage about MTD stock has been trending neutral recently, according to InfoTrie. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mettler-Toledo International earned a news impact score of 0.5 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Mettler-Toledo International.

Some companies that are related to Mettler-Toledo International include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories Intl. (CRL), BIO-TECHNE (TECH), Bruker (BRKR), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mettler-Toledo International investors own include Intuitive Surgical (ISRG), NVIDIA (NVDA), Home Depot (HD), Adobe (ADBE), Booking (BKNG), Alibaba Group (BABA), Allergan (AGN), Lam Research (LRCX), JPMorgan Chase & Co. (JPM) and Mastercard (MA).

Mettler-Toledo International's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (8.52%), WCM Investment Management LLC (4.89%), State Street Corp (4.31%), Fiera Capital Corp (2.95%), Baillie Gifford & Co. (2.68%) and Franklin Resources Inc. (2.30%). Company insiders that own Mettler-Toledo International stock include Christian Magloth, Gerry Keller, Hans Ulrich Maerki, La Guerroniere Marc De, Michael A Kelly, Michael Heidingsfelder, Oliver A Filliol, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas P Salice, Wah-Hui Chu, Waldemar Rauch and William P Donnelly. View Institutional Ownership Trends for Mettler-Toledo International.

MTD stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Acadian Asset Management LLC, Janus Henderson Group PLC, Alliancebernstein L.P., Russell Investments Group Ltd., AXA, First Trust Advisors LP and Fiera Capital Corp. Company insiders that have sold Mettler-Toledo International company stock in the last year include Christian Magloth, La Guerroniere Marc De, Michael Heidingsfelder, Oliver A Filliol, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas P Salice and Wah-Hui Chu. View Insider Buying and Selling for Mettler-Toledo International.

MTD stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Loomis Sayles & Co. L P, Massachusetts Financial Services Co. MA, AQR Capital Management LLC, Renaissance Technologies LLC, Baillie Gifford & Co., Beacon Investment Advisory Services Inc. and Credit Suisse AG. View Insider Buying and Selling for Mettler-Toledo International.

Shares of MTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MTD stock can currently be purchased for approximately $760.22.

Mettler-Toledo International has a market capitalization of $18.28 billion and generates $3.01 billion in revenue each year. The medical instruments supplier earns $561.11 million in net income (profit) each year or $22.77 on an earnings per share basis. Mettler-Toledo International employs 16,200 workers across the globe.View Additional Information About Mettler-Toledo International.

The official website for Mettler-Toledo International is http://www.mt.com/.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The medical instruments supplier can be reached via phone at 614-438-4511 or via email at [email protected]